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Humphrey Awards 
Honoring three leaders in 
the fight against cancer 
The Great H a l l of Boston's r e n o w n e d 
Q u i n c y M a r k e t , b r ightened by the 
rays of an early spring sun, was the 
scene as this year's H u b e r t H . 
H u m p h r e y Cancer Research Center 
Awards were presented to three dis-
t inguished recipients. 
A luncheon gather ing of 250 
watched as the awards were pre-
sented to : 
• Former U.S. Sen. E d w a r d W. 
Brooke, h o n o r e d f o r his e f for t s to 
increase the level of federal support 
f o r cancer research; 
• H a r r y Eagle, M . D . , associate dean 
and director of cancer research at 
A l b e r t Einstein College of Medic ine i n 
N e w York C i t y , h o n o r e d f o r his con-
t r i b u t i o n s to cell biology and the use 
of tissue cultures i n biomedical 
research; and 
• A r m a n d H a m m e r , M . D . , w e l l -
k n o w n industr ia l i s t and c u r r e n t l y the 
cha i rman of the President's Cancer 
Panel, h o n o r e d f o r his phi lanthropic 
support of cancer research. 
H a m m e r was g iven his a w a r d by 
Boston U n i v e r s i t y President John R. 
Silber, w h o noted that the i n d u s t r i a l -
What is the nature of the l ink 
between diet and cancer? 
Humphrey Center scientists are 
helping to shed light on this 
critical, and controversial, sub-
ject. See story, page 4. 
Winners of the awards and others chat during Humphrey awards ceremony. Shown are, from left, Luci 
Baines Johnson, member of the awards committee; University President John R. Silber; former Senator 
Edward Brooke; Armand Hammer, M.D.; Hubert Humphrey's sister, Frances Howard; Harry Eagle, 
M.D., and John 1. Sandson, M.D., dean of Boston University School of Medicine. 
ist's ventures i n in ternat iona l trade 
made h i m "a 2 0 t h - c e n t u r y r i v a l to 
M a r c o Polo." 
" H i s ph i lanthropic career resembles 
his business career," Silber w e n t o n . 
" I t has been careful ly planned, per-
fect ly targeted and open to the tak ing 
of well-calculated risks." 
H a m m e r f i r s t traveled to the Soviet 
U n i o n i n 1921 t o help people v i c t i m -
ized by the heal th problems resul t ing 
f r o m the Russian R e v o l u t i o n , said 
Silber. W h i l e there , he came to Lenin's 
a t t e n t i o n , and was asked by the 
Soviet ru ler to help restore his c o u n -
t r / s trade relat ions w i t h the W e s t — 
an episode that m a r k e d the beginning 
of H a m m e r ' s i n v o l v e m e n t i n i n t e r n a -
t ional trade. 
H a m m e r , d u r i n g the course of brief 
acceptance remarks , made the sur-
prise announcement that he was con-
t r i b u t i n g $50,000 to the H u m p h r e y 
Center 's h y b r i d o m a laboratory . 
(See photo of the lab o n page 8). 
Richard H . Egdahl, M . D . , d irec tor 
of Boston U n i v e r s i t y Medical Center, 
presented the H u m p h r e y a w a r d to 
Brooke. H e compared the honoree's 
c o n t r i b u t i o n s to those of H u m p h r e y , 
saying that " l ike H u b e r t H u m p h r e y , 
Ed Brooke w e l l unders tood h o w to 
use the legislative process to help 
those i n need." 
Egdahl singled o u t Brooke's e f for t s 
to boost federal support f o r cancer 
research d u r i n g the senator's tenure 
as a me m be r of the Senate A p p r o p r i a -
t ions C o m m i t t e e . " H e was a major 
factor i n r i v e t i n g public a t t e n t i o n o n 
continued on page 3 
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FROM THE DIRECTOR 
Dear Friends, 
T h i s n e w publ icat ion . The Humphrey 
Center Report, marks the i n i t i a t i o n of a 
n e w e f f o r t o n o u r part to keep y o u 
i n f o r m e d of Center activities. The 
Report w i l l be published three times a 
year; any c o m m e n t s y o u may have 
are welcome. 
I n M a r c h , w e held o u r t h i r d annual 
H u b e r t H . H u m p h r e y Cancer Research 
Center awards ceremony, at w h i c h 
w e h o n o r e d three o u t s t a n d i n g f igures 
i n the batt le against cancer. T h e con-
t r i b u t i o n s of f o r m e r Sen. E d w a r d 
Brooke, A r m a n d H a m m e r , M . D . , and 
H a r r y Eagle, M . D . , have been d i f f e r -
ent i n nature ; they are alike, however , 
i n w h a t they say about the c o m m i t -
m e n t and fores ight of these three 
m e n . 
T h e recent past also has seen 
steady progress o n the Center 's n e w 
home. I t is to be located i n to ta l ly 
renovated space o n the seventh f loor 
of w h a t was f o r m e r l y the Boston C i t y 
Hospi ta l O u t p a t i e n t B u i l d i n g . W h e n 
completed, i t w i l l help to provide a 
focus and a p o i n t of interchange f o r 
the m o r e t h a n 75 scientists w h o make 
u p the Center 's professional staff . 
We have already received a site vis i t 
f r o m the N a t i o n a l Cancer I n s t i t u t e , 
w h i c h has been asked to provide part 
of the f u n d i n g f o r the project. We are 
opt imis t ic tha t N C I ' s decision w i l l be 
favorable. M e a n w h i l e , o u r thanks to 
those w h o have already supported the 
b u i l d i n g campaign. We are p a r t i c u -
lar ly g r a t e f u l f o r the substantial 
assistance pledged by the Louis B. 
M a y e r Foundat ion , C l i f f o r d and 
Phyll is Seresky, and the Raytheon 
C o m p a n y . 
T h e basic mission of the Center is 
cancer research, of course, and the 
recent past has seen impressive p r o -
gress o n m a n y f r o n t s . O n e advance 
tha t attracted considerable public 
notice was the r e p o r t by one of o u r 
staff members , Frederick M o o l t e n , 
M . D . , that he had developed a vaccine 
tha t successfully protected exper i -
m e n t a l animals against a cancer-
causing agent. 
I n addi t ion , t w o staff members , 
Michael Osband, M . D . , and Ronald 
M c C a f f r e y , M . D . , reported i n the New 
England journal of Medicine that they had 
developed a t r e a t m e n t tha t corrects 
an imbalance i n the i m m u n e system 
associated w i t h the children's disease 
called Hist iocytosis-X. A l t h o u g h this 
is a v e r y rare condi t ion , the t r e a t m e n t 
is expected to be applicable to several 
other, more c o m m o n ai lments . 
T h e Center's research activities, as 
m a n y of y o u k n o w , are organized 
a r o u n d w o r k i n g groups . These 
groups have been set up i n order to 
p r o m o t e close and f requent i n t e r -
changes among Center staff members 
involved i n similar areas. 
So far, six of the w o r k i n g groups 
are i n place. T h e y are the groups foc-
using o n cancer as i t relates to : n u t r i -
t i o n ; cell biology; n e w strategies i n 
cancer therapy; hormones ; the under-
l y i n g causes of the disease; and 
advances i n t r e a t m e n t methods (the 
last is designed especially f o r staff 
members involved i n clinical w o r k ) . 
T h e seventh g r o u p , concerning cancer 
and the i m m u n e system, w i l l be set 
up over the course of the coming 
m o n t h s . 
As part of o u r research role, w e 
seek to extend knowledge about 
recent advances to the broader 
research c o m m u n i t y . O n e part of this 
e f f o r t is the annual Sidney R. Cooper-
band Sympos ium, named f o r the C e n -
ter's f i r s t director. The t h i r d i n the 
s y m p o s i u m series was held i n 
November , w i t h Robert K . O l d h a m , 
M . D . , d irector of the NCI ' s Frederick 
Cancer Research Center i n Frederick, 
M d . , as lead presenter, and d r e w a 
g r a t i f y i n g level of part ic ipat ion. For-
tunate ly f o r all of us, O l d h a m 
remained at B U S M for several days i n 
his role as the f i r s t Charles E. C u l -
peper V i s i t i n g Professor i n 
I m m u n o l o g y . 
T h e Center also supports a v a r i e t y 
of lecture series. A c u r r e n t one, spon-
sored j o i n t l y w i t h the D i v i s i o n of Psy-
chia try , is o n the fascinating subject 
of the role played by menta l processes 
i n p r o m o t i n g or suppressing t u m o r s . 
The Center also tries to c o m m u n i -
cate knowledge to physicians and 
nurses involved i n t reat ing cancer. 
This is done t h r o u g h o u r Regional 
Oncology Program, under the direc-
t i o n of Peter Deckers, M . D . P r o g r a m 
seminars are held at several hospitals 
t h r o u g h o u t southeastern Massachu-
setts, and cont inue to d r a w an e n t h u -
siastic response f r o m pract i t ioners . 
T h e period ahead promises to be at 
least as e v e n t f u l as the last several 
m o n t h s have been. O n e major m i l e -
stone w i l l be o u r application f o r 
renewal of core f u n d i n g f r o m N C I , 
scheduled for the fal l . Here again, w e 
are opt imist ic . Whatever the f u t u r e 
may ho ld , t h o u g h , the Center is today 
a v i b r a n t and active organizat ion , 
w i t h a range of research under tak ings 
that is t r u l y exci t ing to all of us. 
Regards, 
Paul H . Black, M . D . 
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Center will occupy top floor of this building, shown here in artist's rendering. 
Work proceeds on Center's new home 
Awards... 
continued from page 1 
the importance of adequate f u n d i n g 
f o r b o t h clinical and basic research i n 
cancer." 
The t h i r d honoree . Eagle, was 
characterized by John I . Sandson, 
M . D . , dean of Boston U n i v e r s i t y 
School of Medic ine , as a "statesman of 
science, one w h o understands h o w to 
make practical the f indings of the 
research labora tory . " 
Eagle, he noted , was a member of 
the U.S. Public fdealth Service f r o m 
1936 to 1961 , and d u r i n g that period 
rose to become chief of the Labora-
t o r y of Cell Biology at the Nat iona l 
Inst i tute of A r t h r i t i s and Infect ious 
Disease. 
D u r i n g the luncheon gather ing , 
Paul H . Black, M . D . , director of the 
H u m p h r e y Center, provided an 
update o n Center activities over the 
past year. Boston M a y o r K e v i n W h i t e 
and a representative of Gov. E d w a r d 
K i n g also spoke. 
The awards p r o g r a m was estab-
lished three years ago w h e n the C e n -
ter was renamed f o r the late M i n n e -
sota Senator and 3 8 t h Vice President 
of the U n i t e d States. I n addi t ion to 
M u r i e l H u m p h r e y B r o w n , previous 
awardees have been: Sidney Cooper-
band, M . D . , the Center 's f i r s t director 
(posthumous) ; D a v i d Bal t imore , 
Ph .D. , the A m e r i c a n Cancer Society 
Professor of M i c r o b i o l o g y at the Mas -
sachusetts I n s t i t u t e of Technology 
and w i n n e r of a Nobe l prize f o r his 
research o n the in terac t ion between 
t u m o r viruses and the cell; Marve l la 
Bayh, the late w i f e of U.S. Sen. B i rch 
Bayh, h o n o r e d f o r her e f for t s to edu-
cate the public about the importance 
of cancer p r e v e n t i o n (posthumous) ; 
M a r y W. Lasker, a p h i l a n t h r o p i s t and 
the organizer, along w i t h her hus-
band, of the A m e r i c a n Cancer Socie-
ty's f i r s t public f u n d r a i s i n g appeal; 
and George T h o r n , M . D . , f o r m e r l y 
physician-in-chief at Peter Bent 
B r i g h a m H o s pi ta l and a professor at 
the H a r v a r d Medical School, w h o was 
cited f o r his research o n the role of 
hormones and the adrenal gland i n 
cancer development . 
T h e H u b e r t H . H u m p h r e y Cancer 
Research Center c u r r e n t l y has a 
s t rong organizat ional i d e n t i t y b u t 
lacks a physical one: There is no place 
i t can call home. 
T h a t circumstance is expected to 
change w i t h i n about a year, t h o u g h , 
w h e n the Center 's headquarters and 
some of its labs move i n t o the f o r m e r 
Boston C i t y Hospi ta l O u t p a t i e n t 
B u i l d i n g , located across the street 
f r o m the School of Medic ine . 
T h e seven-story s t ruc ture , w h i c h 
has n o t been i n use since the hospi -
tal's n e w A m b u l a t o r y Care Center 
opened i n 1978, is being to ta l ly reno-
vated. W h e n the w o r k is d o n e — w h i c h 
is scheduled f o r mid-1983—the 
H u m p h r e y Center w i l l occupy the t o p 
f loor, and other elements of the 
School of Medic ine and U n i v e r s i t y 
Hospi ta l w i l l occupy the remainder. 
T h e bu i l d ing w i l l be called the Boston 
U n i v e r s i t y School of Medic ine C e n -
ters f o r Advancement i n H e a l t h and 
Medic ine . 
The H u m p h r e y Center 's f l o o r is 
being renovated and equipped at a 
cost of approximate ly $1.2 m i l l i o n . 
T h e Center has applied to the 
N a t i o n a l Cancer Ins t i tu te f o r r o u g h l y 
half the cost, and w i l l raise the rest 
t h r o u g h a u n i f i e d f u n d r a i s i n g cam-
paign w i t h the o ther prospective 
occupants of the b u i l d i n g . 
The n e w faci l i ty w i l l play an i m p o r -
tant role i n focusing and coordinat ing 
the Center's w i d e - r a n g i n g research 
enterprises, said Isaac M . Taylor, 
M . D . , associate director f o r adminis -
t r a t i o n . I n addi t ion , i t w i l l provide 
laboratory and office space f o r several 
of the Center's m o r e t h a n 75 profes-
sional staff members . 
Several major donat ions already 
have been made to support develop-
m e n t of the Center faci l i ty . T h e y 
have come f r o m : 
• the Louis B. M a y e r Foundat ion , 
w h i c h is suppor t ing development of 
the t u m o r cell biology laboratory ; 
• C l i f f o r d and Phyllis Seresky of C a n -
t o n , Mass., w h o are suppor t ing devel-
o p m e n t of the i m m u n o l o g y lab; M r . 
Seresky is the b r o t h e r of Selma 
Cooperband, w i d o w of the f i r s t direc-
t o r of the Cancer Center ; and 
• the Raytheon C o m p a n y , w h i c h is 
m a k i n g its f i r s t corporate d o n a t i o n to 
a school of medicine i n p r o v i d i n g sup-
p o r t f o r the Center 's n e w faci l i ty . 
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Cancer and Diet: 
Probing the nature of 
the connection 
Few subjects have been s u r r o u n d e d 
by more confus ion and controversy 
t h a n the l i n k be tween diet and cancer. 
T h a t there is a l i n k is w i t h o u t 
do u bt . Studies of stomach cancer, f o r 
example, have s h o w n that w h e n peo-
ple move f r o m Japan, w h i c h has a 
v e r y l o w stomach cancer rate, to the 
U n i t e d States, w h i c h has a h igher 
rate, the i r chances of contrac t ing the 
disease rise u n t i l they approximate 
those of U.S. natives. 
Studies of d i f f e r e n t populat ions i n 
the U.S. also argue f o r a diet-cancer 
connect ion. The rate of colon cancer 
a m o n g M o r m o n s , f o r example, is 
m u c h l o w e r t h a n the U.S. average. 
Scientists believe the m a i n reason is 
the M o r m o n diet , w h i c h includes no 
s t imulants or alcohol and is h i g h i n 
vegetables and f r u i t . 
U n f o r t u n a t e l y , the nature of the 
diet-cancer re lat ionship is st i l l poor ly 
unders tood. M u c h of the i n f o r m a t i o n 
about i t has come f r o m studies l ike 
those of the experience of Japanese 
i m m i g r a n t s to Amer ica . Such studies 
can of fer clues to the kinds of food 
th a t need a t t e n t i o n . T h e Japanese 
diet, f o r example, is h i g h i n f i sh . B u t 
the studies do not p i n p o i n t h o w spe-
cific foods and n u t r i e n t s affect the 
development of cancer. 
" I n l i gh t of the increasing support 
w i t h i n the scientific c o m m u n i t y f o r 
the concept that diet and n u t r i t i o n 
m i g h t play a major role i n the i n i t i a -
t i o n and progression of certain 
h u m a n cancers," said Paul Fi. Black, 
M . D . , Fdumphrey Center director, 
" there is a need f o r scientists to c lar i fy 
the nature of the interact ion . Several 
of the invest igators at the H u m p h r e y 
Cancer Research Center are involved 
i n studies that w i l l accomplish exactly 
t h a t . " 
O n e g r o u p of investigators at the 
Center, f o r example, is focusing o n 
the role of fats i n p r o m o t i n g cancer. 
Included i n their research is an e x a m -
i n a t i o n of one of the most medically 
r e n o w n e d of all components of the 
diet—cholesterol . 
O t h e r researchers are looking at 
the role of v i tamins i n cont r o l l in g 
t u m o r g r o w t h . One series of studies 
focuses o n v i t a m i n E, the n u t r i e n t 
tha t is most c o m m o n l y f o u n d i n 
vegetable oils. A n o t h e r series involves 
v i t a m i n A , the n u t r i e n t that is f o u n d 
i n such foods as carrots, eggs, f i sh 
and leafy vegetables, and is cri t ical to 
sustaining good eyesight. 
The puzzling case of 
cancer and cholesterol 
"There certainly is a correlat ion 
between a h igh- fa t diet and cancer, 
just as there is a correlat ion w i t h car-
diovascular disease," said Joseph J. 
Vi ta le , M . D . , Sc.D., director of the 
Boston U n i v e r s i t y School of Medic ine 
n u t r i t i o n education p r o g r a m and a 
professor of pathology. 
O n the other hand, the strategy 
advised f o r c u t t i n g the risk of heart 
disease—substituting polyunsaturated 
fats, like those i n corn o i l , f o r the sat-
urated fats f o u n d in m i l k and 
b u t t e r — m a y not protect against 
cancer. 
The reason, said Vita le , is th a t 
polyunsaturated fats, w h i l e l o w i n 
cholesterol, may have the paradoxical 
effect of increasing cholesterol levels 
i n the intest inal tract . 
Cholesterol , he explained, is an 
essential component of the h u m a n 
makeup, f o r m i n g a part of every cell 
i n the body. I n addi t ion, said Vi ta le , 
the body has the abi l i ty to regulate its 
cholesterol levels. T h u s , i n general , he 
said, " i f y o u eat more cholesterol, 
y o u r body makes less, and vice versa." 
Subs t i tu t ing polyunsaturated fats 
f o r saturated fats does i n fact cut 
blood levels of cholesterol. Yet the 
unsaturated fats appear to accomplish 
this by affect ing the regula tory mech-
anism i n such a w a y that the " e x t r a " 
cholesterol and other cholesterol-l ike 
substances—the a m o u n t removed 
f r o m the blood—enters the intes t inal 
tract . 
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Is this added cholesterol i n the g u t 
something to w o r r y about? Yes i t is, 
said S e l w y n A . B r o i t m a n , Ph .D. , a 
B U S M professor of microbio logy and 
n u t r i t i o n a l sciences. 
" I f w e feed diets h i g h i n cholesterol 
to exper imenta l animals, and t h e n 
inject a substance k n o w n to cause 
t u m o r s i n t o the animals, the n u m b e r 
of large-bowel t u m o r s w i l l go u p , " 
B r o i t m a n explained. Th is s imply i n d i -
cates tha t a h i g h - f a t diet increases the 
risk of cancer—a f i n d i n g also sup-
por ted by studies of cancer patterns 
among h u m a n s . 
" O n the o ther h a n d , " said the 
microbiologist , " i f w e reduce s e r u m 
cholesterol levels by feeding the 
animals po lyunsaturated fats, tha t 
also increases the n u m b e r of large-
b o w e l t u m o r s . " Th is s t rongly sug-
gests tha t the po lyunsatura ted fats 
are raising cholesterol levels i n the 
intest inal system. 
There is a var ie ty of theories about 
h o w cholesterol promotes t u m o r s , 
most of t h e m focusing o n its impact 
on the body's i m m u n e system. 
As Vitale noted , there is s t rong 
evidence tha t cholesterol tends to 
reduce i m m u n i t y . This may occur, he 
said, t h r o u g h its effect o n a key c o m -
ponent of the i m m u n e system called 
the macrophage—a cell that has the 
capacity to absorb or o therwise p r o -
tect against such dangerous i n t r u d e r s 
as toxic chemicals or infect ious bacte-
ria , and to k i l l t u m o r cells. 
"To f u n c t i o n p r o p e r l y , " said Vi ta le , 
"a macrophage has to have a certain 
level of f l u i d i t y . I f y o u make i t too 
f l u i d — t o o re laxed—it w o n ' t w o r k . 
A n d i f y o u make i t too r i g i d , i t w o n ' t 
w o r k . " 
Recent research, he added, shows 
tha t cholesterol plays a key role i n 
d e t e r m i n i n g the f l u i d i t y of cells. 
T h u s , w h a t cholesterol may be doing 
is essentially d isarming one of the 
body's leading defenders against 
cancer. 
C u r r e n t l y , B r o i t m a n , Vi ta le and 
the i r colleagues are p u r s u i n g answers 
to a range of s t i l l -pending questions 
o n the cancer-cholesterol l i n k , and o n 
the more general issue of the role of 
dietary fats i n p r o m o t i n g cancer and 
af fect ing the i m m u n e system. 
O n e of the i r m a i n projects is to 
keep detailed records of the foods 
consumed by a g r o u p of cancer 
patients. This p r o j e c t — w h i c h also 
involves analysis of the pat ients ' b lood 
and other measures tha t w i l l provide 
i n f o r m a t i o n about the group's d ie tary 
patterns—is intended to c lar i fy w h a t , 
up to n o w , has been a disputed 
subject. 
T r y i n g to tel l f r o m personal recol-
lections h o w m u c h fat an i n d i v i d u a l 
consumes is v e r y d i f f i c u l t , B r o i t m a n 
said. M a n y foods, like meat, have 
w i d e l y v a r y i n g amounts of fat , and 
cooking can c o m p o u n d the d iver -
gence. "We're t r y i n g to f i n d a d i f f e r -
ence of 5 to 10 percent i n fat con-
s u m p t i o n f r o m patient to pat ient , and 
y o u just can't do that by r e l y i n g o n 
recollections." 
T h u s , this s tudy could help to p r o -
vide one of the f i r s t accurate p o r t r a y -
als of h o w fat intake relates to the 
g r o w t h or suppression of t u m o r s . 
Research of this k i n d w i l l u l t i m a t e l y 
provide doctors w i t h clear guidance 
about h o w fat intake should be 
adjusted i n cancer patients. B r o i t m a n 
expects that w i t h i n about f ive years, 
e n o u g h w i l l be k n o w n so t h a t regula t -
i n g the amounts of fat patients eat 
w i l l start becoming a n o r m a l part of 
cancer therapy. 
Selwyn Broitman, Ph.D. 
Joseph Vitale, M.D., Sc.D. 
Signs of an anti-tumor 
role for vitamins 
V i t a m i n s A and E are w i d e l y recog-
nized as i m p o r t a n t n u t r i e n t s . Every 
cereal box lists t h e m , along w i t h 
o ther n u t r i e n t s , as essential parts of 
each person's diet. 
Cereal boxes, however , do n o t 
explain w h y these substances are 
i m p o r t a n t , n o r h o w they are used by 
the body. Research n o w under w a y at 
the H u m p h r e y Center is helping to 
i l luminate such questions as they 
relate to prevent ing and t rea t ing 
cancer. 
O n e of the investigators in vo lved 
i n v i t a m i n E studies is Laurence C o r -
w i n , Ph .D. , a professor of m i c r o b i o l -
ogy and n u t r i t i o n a l sciences at B U S M . 
A n i m a l experiments carried o u t by 
C o r w i n and his colleagues have 
s h o w n a clear connect ion be tween 
v i t a m i n E and cancer. " I f y o u give a 
h i g h dose of v i t a m i n E to laboratory 
animals," he explained, "and t h e n sub-
ject t h e m to a carcinogen, y o u f i n d 
the n u t r i e n t w i l l decrease the inc i -
dence of t u m o r s to a h i g h l y s ign i f i -
cant degree." 
A n i n t r i g u i n g outcome, b u t w h a t 
accounts f o r it? 
According to C o r w i n , other exper-
iments have convinc ingly s h o w n that 
v i t a m i n E st imulates the i m m u n e sys-
t e m . This is i m p o r t a n t because of the 
nature of cancer cells. " M o s t h u m a n 
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t u m o r s are v e r y poor at generat ing 
an i m m u n e response," he said, "and 
this is w h y they are so d a m a g i n g — 
they are able to g r o w w i t h o u t g e t t i n g 
the body's n a t u r a l defenses activated." 
I n seeking answers to the quest ion 
of h o w v i t a m i n E energizes the 
i m m u n e system, C o r w i n and his col-
leagues have been focusing o n chemi -
cal changes that occur o n the cell sur-
face. These changes, w h i c h are g iven 
the generic t i t le of antigens, t r igger 
the i m m u n e system. T h e system, i n 
t u r n , can t h e n go to w o r k to destroy 
or remove the cancerous cells. 
C o r w i n and his f e l l o w invest igators 
have f o u n d that the antigens present 
i n the t u m o r cells they are s tudying 
do n o t s t imulate the i m m u n e system 
v e r y w e l l . 
W h y not? O n e p r o m i s i n g t h e o r y , 
said the microbiologist , is that some-
t h i n g is chemically masking the a n t i -
gens and thus p r e v e n t i n g t h e m f r o m 
t r i g g e r i n g an i m m u n e response. T h a t 
someth ing , they believe, is a sub-
stance called sialic acid. 
" I t has been f o u n d tha t m a n y 
t u m o r cells have an increased sialic 
acid content compared w i t h other 
kinds of cells," said C o r w i n . "We did 
some exper iments , and w e f o u n d that 
t u m o r cells w i t h v i t a m i n E had less 
sialic acid t h a n those w i t h o u t i t . " 
T h e next step i n the research w i l l 
be to t r y to complete the loop by 
d e m o n s t r a t i n g tha t antigens are more 
l ikely to s t imulate the i m m u n e system 
w h e n cells c a r r y i n g t h e m have been 
treated w i t h v i t a m i n E. I n addi t ion , 
there w i l l be an e f f o r t made to iden-
t i f y the antigens invo lved . 
T h e research o n v i t a m i n E opens 
some exci t ing possibilities i n terms of 
t rea t ing and possibly p r e v e n t i n g 
cancer. U n l i k e o ther n u t r i e n t s , 
v i t a m i n E is non- tox ic : Large doses 
can be ingested w i t h o u t m a k i n g peo-
ple sick. I n fact, C o r w i n already is 
involved i n a s tudy i n w h i c h v i t a m i n 
E is being g iven to a g r o u p of people 
to see h o w i t affects the i r i m m u n e 
systems. 
Aside f r o m uses i n therapy, 
another long-range possibil i ty is the 
development of a m e t h o d f o r i m m u n -
iz ing people against some f o r m s of 
cancer, just as people today are 
i m m u n i z e d against diseases like mea-
sles and polio. "It 's d e a r l y n o t feasible 
to i m m u n i z e against cancer by using a 
t u m o r cell ," C o r w i n said. " B u t i f w e 
k n o w w h a t ant igen protects against a 
part icular f o r m of cancer, maybe that 
ant igen can be used to provide 
i m m u n i t y . " 
Besides v i t a m i n E, another essential 
n u t r i e n t , of course, is v i t a m i n A . As 
w i t h v i t a m i n E, there is s t rong evi -
dence that v i t a m i n A may help p r o -
tect against cancer. 
E d w a r d Schroder, Ph .D. , an assist-
ant professor of microbio logy at 
B U S M and a H u m p h r e y Center 
member, is one of the investigators 
involved i n v i t a m i n A research. "Sev-
eral studies have s h o w n that i f exper-
imenta l animals are deprived of 
v i t a m i n A , they are at h igher r isk of 
developing certain types of t u m o r s , " 
Schroder explained. 
O t h e r exper iments , he added, have 
demonstrated the corol lary: T h a t 
v i t a m i n A is h e l p f u l i n reducing the 
r isk of such f o r m s of the disease as 
breast, colon and bladder cancer. 
N o t at all clear, t h o u g h , are the 
mechanisms by w h i c h v i t a m i n A does 
this . Schroder and his colleagues are 
t r y i n g to f i n d o u t w h a t these mecha-
nisms are. 
T h e y have been w o r k i n g w i t h a 
derivat ive of v i t a m i n A called ret inoic 
acid, and focusing specifically o n the 
quest ion of h o w i t affects cell g r o w t h . 
T h r o u g h this w o r k they have discov-
ered tha t w h e n i t is applied to t u m o r 
cells f r o m rodents , retinoic acid w i l l 
s low the rate at w h i c h the cells divide . 
T h e i r research also suggests that the 
s l o w - d o w n is l inked to ret inoic acid's 
effect o n levels of a substance called 
adenosine-tr iphosphate, or ATP, 
w h i c h is k n o w n to regulate the rate 
at w h i c h cells divide. 
The next step, said the investigator, 
w i l l be to t r y to tie the ir f indings to 
h u m a n cancer. "We are going to look 
at cells derived f r o m h u m a n t u m o r s , 
to see w h e t h e r their A T P levels also 
are affected by retinoic acid, and 
w h e t h e r changes i n A T P are corre-
lated w i t h changes i n cell g r o w t h , and 
i n the expression of other properties 
of t u m o r cells." 
A n d w h a t about potent ia l applica-
t ions i n t reat ing cancer? There is a 
need f o r caut ion i n p u t t i n g v i t a m i n A 
to w o r k i n t reat ing patients, Schroder 
said, because, unl ike v i t a m i n E, large 
doses of v i t a m i n A can have toxic 
effects. Nevertheless, the n o t i o n of a 
substance that can s low the rate at 
w h i c h cells replicate—the basic p r o -
cess that drives t u m o r grow th —r a is es 
the prospect of m a k i n g signif icant 
inroads against m a n y f o r m s of cancer. 
Edward Schroder, Ph.D. 
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RESEARCH PROFILE 
Hugues ].-P. Ryser, M.D. 
For most his career, Hugues J.-P. 
Ryser, M.D. , has been engaged in one 
form or another of basic research. 
It is research that may, in time, 
help to promote major advances in 
cancer treatment. For example, his 
work on the question of how large 
molecules penetrate cells, and how 
they are "digested" once inside, is 
directly applicable to cancer drugs. 
Thus, it could lead to methods for 
speeding the entry of drugs into 
tumor cells, and improving their 
effectiveness once they are in there. 
Such applications, however — as 
Ryser himself emphasizes — lie far 
down the road. There is a need for a 
lot more experimentation, and many 
obstacles remain to be overcome. 
Yet that has not discouraged Ryser, 
a professor of pathology, biochemis-
try, pharmacology and public health, 
and a member of the Cancer Center. 
He is deeply committed to involve-
ment in basic research, and obviously 
enjoys it . 
The commitment, though, is not 
one that dates back to his student 
days. For like many biomedical inves-
tigators, Ryser started out in medi-
cine assuming that he would be a 
physician in practice. 
Thus, although he took a research 
position after graduating from medi-
cal school in his native Switzerland, 
he did not see that as the start of a 
career in research. 
" I had gone to medical school to be 
a doctor, I wanted to be a doctor and I 
felt I would be very good at being a 
doctor," he says. Thus, after about a 
year in research, he said to himself, 
"enough of this nonsense. I am now 
going to do my internship and my 
residency". 
He signed on at one of the leading 
hospitals in Switzerland. Yet even 
there, more or less by accident, he 
wound up devoting some of his time 
to research. 
Eventually concluding that research 
was perhaps where his future lay 
after all, he began looking for a posi-
tion in the United States. 
" In the late '50s," he says, "the Uni-
ted States was by all odds the center 
of biomedical research in the world. 
Boston was a particularly active area, 
as it is today." 
The young physician was appointed 
as a research and clinical fellow at the 
Massachusetts General Hospital. His 
main focus, initially, was clinical re-
search. But then he began looking at 
how large molecules penetrate cells. 
" I found out that I was much hap-
pier doing research at the cellular 
level than I was at the level of a very 
complex disease," he recalls. "This 
probably has something to do w i t h 
the fact that my mind functions in a 
mostly analytical way. I'm very com-
fortable analyzing basic phenomena." 
Fascinated by the subject of mac-
romolecules and cells, Ryser pursued 
it even though, at that time, there 
was dispute wi th in the scientific 
community about whether large 
molecules could even get into cells. 
As the result of his tenacity, Ryser 
in 1968 received the kind of recogni-
tion that comes rarely to a young 
scientist. He was asked to write a 
major article on macromolecular 
uptake by cells for the journal Science. 
"There was a tremendous response 
to the article," he says. "Most of it 
was favorable, but there was a lot of 
condescending criticism, too." 
Although Ryser wil l disclaim major 
responsibility, the field of macromo-
lecular transport took off in the 
period following the article's appear-
ance and it remains a major field of 
interest today. 
The investigator^s own work, of 
course, has gone far beyond simply 
examining how large molecules enter 
cells. One of the main areas that he 
and his associates, Wei-Chiang Shen, 
M.D. , and Richard Mandel, M.D. , are 
pursuing involves conjugates—that is, 
two molecules that have been chemi-
cally linked. 
"We found many years ago that the 
uptake of macromolecules by cells 
increases markedly if they are linked 
to certain other types of 
macromolecules—those w i t h a strong 
positive charge," he says. The increase 
in the rate of penetration can be 
enormous—as much as 1,000 times 
what it is for unlinked molecules. 
The potential usefulness of this 
finding lies in the fact that cancer 
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drugs are n o t readily able to penetrate 
cells. M o r e recent w o r k , says Ryser, 
has s h o w n that the a m o u n t of an 
anti-cancer d r u g called methotrexa te 
t h a t gets i n t o t u m o r cells g r o w i n g i n 
test-tubes can be increased t r e m e n d -
ously t h r o u g h the l inkage system. 
W h i l e Ryser and his associates are 
t r y i n g to increase unders tanding of 
the role of macromolecules i n pene-
t r a t i n g cells, the invest igator is also 
proceeding along m a n y other scien-
t i f ic pathways . Some of these o ther 
projects ma y t u r n o u t to have early 
practical applications. His s tudy of 
h o w c a d m i u m and ni trosamines i n t e -
ract to increase the r isk of cancer, f o r 
example, w i l l help r e g u l a t o r y agencies 
decide w h a t levels of cancer-causing 
substances to p e r m i t i n the 
e n v i r o n m e n t . 
For the most par t , t h o u g h , his w o r k 
is basic research u p o n w h i c h o ther 
invest igators w i l l be able to b u i l d — a 
fact tha t i n n o w a y diminishes Ryser's 
convic t ion about its importance . 
" N o t h i n g w o u l d happen, i n m e d i -
cine or any other area of science, i f 
people did not f i r s t develop a certa in 
intel lectual cur ios i ty about a p h e n o m -
e n o n , " he says. "There are some 
people—and I happen to be one of 
t h e m — w h o are cur ious about w h a t is 
go ing o n i n na ture . A n d basic 
research is really jus t a systematic 
w a y of t r y i n g to f i n d o u t . " 
Ann Marshak-Rothstein, Ph.D., (right) an assistant professor of microbiology and director of the hybri-
doma lab, chats with Aid for Cancer Research member Louise Shivek during dedication. 
New hybridoma lab is dedicated 
T h e H u m p h r e y Center 's n e w h y b r i -
doma lab, made possible t h r o u g h a 
donat ion by the Boston-area char i t -
able g r o u p A i d f o r Cancer Research, 
was dedicated i n M a r c h . 
T h e fac i l i ty is being used i n one of 
the most exci t ing areas of cancer 
research—the creation of hybr idomas . 
These are combinat ions of a cancer-
ous cell w i t h a non-cancerous cell. 
T h e y are valuable because they a l low 
creat ion of t u m o r - f i g h t i n g substances 
called antibodies. 
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Tradi t ional ly , antibodies f o r use i n 
either research or t r e a t m e n t have 
been produced by using exper imenta l 
animals. This , however , is a s low and 
expensive process. W i t h the use of 
hybr idomas , antibodies can be p r o -
duced m u c h m o r e rapidly, and i n 
large quanti t ies w h e n necessary. 
T he reason f o r l i n k i n g the t w o 
types of cells is that t u m o r cells are 
essentially i m m o r t a l , whereas the 
n o n m a l i g n a n t ce l l s—which generate 
the a n t i b o d i e s — w o u l d die too quick ly 
to p e r m i t eff ic ient p r o d u c t i o n of 
antibodies i f they weren ' t l inked to a 
cancerous cell. 
A i d f o r Cancer Research c o n t r i b -
uted $51,000 to equip the n e w lab. 
W e l l - k n o w n industr ia l is t A r m a n d 
H a m m e r , M . D . , one of this year's 
H u m p h r e y Center award w i n n e r s , 
also has c o n t r i b u t e d $50,000 f o r the 
operat ion of the lab. 
